Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
Top Cited Papers
Open Access
- 25 October 2012
- journal article
- practice guideline
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (2), 175-184
- https://doi.org/10.1002/pbc.24367
Abstract
These guidelines for the management of patients up to 18 years with Langerhans cell histiocytosis (LCH) have been set up by a group of experts involved in the Euro Histio Net project who participated in national or international studies and in peer reviewed publications. Existing guidelines were reviewed and changed where new evidence was available in the literature up to 2012. Data and publications have been ranked according to evidence based medicine and when there was a lack of published data, consensus between experts was sought. Guidelines for diagnosis, initial clinical work‐up, and treatment and long‐term follow‐up of LCH patients are presented. Pediatr Blood Cancer 2013;60:175–184.Keywords
This publication has 63 references indexed in Scilit:
- B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric DiseasePLOS ONE, 2012
- Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective studyOrphanet Journal of Rare Diseases, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinosidePediatric Blood & Cancer, 2009
- Cholesteatoma Secondary to Temporal Bone Involvement by Langerhans Cell HistiocytosisOtology & Neurotology, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosisEuropean Journal of Cancer, 2006
- Caring for survivors of childhood cancers: The size of the problemEuropean Journal of Cancer, 2006
- Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionEuropean Journal of Cancer, 2005
- Endocrine involvement in pediatric-onset langerhans' cell histiocytosis: a population-based studyThe Journal of Pediatrics, 2004